Pfizer Wins 2d Trial in Zoloft Birth Defect Case Posted on June 11, 2015 by Larry Bodine From Reuters A jury in Philadelphia ruled that Pfizer Inc. properly warned about the risks that its Zoloft antidepressant could cause birth defects and isn’t responsible for a girl’s heart abnormalities. It is the drugmaker’s second win in cases over the medication. The Philadelphia jury rejected Mia Robinson’s claims that Pfizer officials hid Zoloft’s birth-defect risks and should pay at least $2.4 million to compensate the eight-year-old girl for her heart abnormalities. Read the full story from Reuters The company persuaded a St. Louis jury in April to reject a family’s arguments that the drug caused a boy’s cardiac abnormalities in the first of more than 1,000 lawsuits over the medication to go to trial. Zoloft is best-selling antidepressant on the market. The case is Robinson v. Wolters Kluwer Health Inc., July Term, 2011, No. 778, Control No. 14123047, Pennsylvania Court of Common Pleas of Philadelphia County (Philadelphia).